Caroline Daly

Executive Leader at Poppulo (Vista Equity Partners) | Pre-Seed Investor

📍 Ireland🔄 Updated September 2026💼 7 investments📅 5 years investing🗓 Last invested Dec 2022
Angel investor🌍 Ireland
7
Total investments
5
Early stage
1
Mid stage
1
Late stage
5y
Years active

Portfolio

7 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Dec 2022
An aggregate marketplace for all lifestyle subscriptions.
Investor
Jul 2022
The Happiness Index helps organisations measure the key employee engagement AND happiness drivers to power their people strategy. Our unique platform offers the products, insights and tools to shine a light on your cultural health and empower management to drive thriving cultures. This helps you understand how employees think, feel and behave in real-time. Our neuroscience-based pre-built surveys measure the full employee experience - from onboarding to exit. By measuring the heart and brain of your organisation, we empower and enable managers to move from feedback to insight to action seamlessly. * Book a demo today - https://thehappinessindex.com/demo/ *
Investor
Apr 2022
Tipple allows alcohol brands to sell directly to consumers across 11 European countries. We handle taxes and logistics allowing you to focus on growing your brand.
Investor
Feb 2022
The ultimate insurance and retirement platform for modern companies. We make it extraordinarily easy to roll out and manage benefits globally.
Investor
Dec 2021
Occuitys mission is to improve the lives of hundreds of millions of people by developing painless, contact-free screening & monitoring solutions for health conditions such as #diabetes, #myopia, #glaucoma and #Alzheimers Disease. Occuity is a UK-based medical technology company specialising in the research, design, and production of handheld non-contacting optical instruments for use in healthcare, diagnostics, and monitoring. Occuity’s scanning technology uses light to obtain precise measurements of different structures within the eye. This will enable direct measurements of the eye for optometrists and ophthalmologists but also other more general health conditions such as diabetes and Alzheimer’s Disease to be monitored. Occuitys IP includes 9granted international patents with a further 5 applications. Our Products Optometry & Ophthalmology: Were designing and developing a range of handheld, optical non-contacting devices. Our first device will be the world’s first handheld, non-contacting optical pachymeter – The Occuity PM1 – due to launch in 202. The underlying technology in the PM1 will be built upon to look at other measurements within the eye including, axial length, pupillometry and keratometry for use in both human and veterinary optometry. Disease Screening Building upon our patented technology, Occuitys disease screening products, will make it easier and cheaper to screen for diseases such as diabetes and Alzheimers in non-clinical settings such as high street opticians, pharmacies and care homes. Disease Monitoring Occuity’s vision is to deliver the world’s first non-invasive, non-contacting glucose monitor. Instead of relying on finger stick blood tests to provide blood glucose readings, Occuity is in the process of researching & developing a non-contact handheld optical device to determine the blood glucose level by measuring subtle changes within the anterior chamber of the eye.
Investor
Sep 2021
At Hydrate, we are not just making soft drinks, we are engineering the future of hydration through scientific innovation and advanced R&D. OUR MISSION: VISION 2030 Vision 2030 is our commitment to eliminating sugar, artificial sweeteners, and preservatives from soft drinks, without compromising on taste, function, or refreshment. We are pioneering the next generation of clean-label soft drinks, powered by scientific precision and breakthrough technology. For decades, the soft drinks industry has been stuck in the past, locked in a cycle of sugar and artificial substitutes. We reject both. Instead, we are engineering the future through groundbreaking R&D, next-gen technology, and precision formulation. Our Innovation Centre is the heart of this revolution, an R&D powerhouse where technical experts, engineers, and product developers push the boundaries of what’s possible. From advanced bioconversion to molecular-level flavour engineering, we are building a new class of soft drinks, where performance, purity, and taste exist without compromise. We are not here to make small changes. We are here to redefine the entire category. 💡 Science-Driven. R&D-Led. Innovation at Scale. 🌍 Zero Sugar. No Artificial Ingredients. Unstoppable Innovation. 🚀 Join us. The countdown to better soft drinks starts now.
Investor
Sep 2021
GoFIGR (formerly Flow of Work) connects the skills and aspirations of your employees to existing opportunities within your business, helping find, inspire, grow and retain critical talent.
Experience · 7 entries
All (7)
Investments (7)
2022
Investor
Dec 2022
An aggregate marketplace for all lifestyle subscriptions.
Investor
Jul 2022
The Happiness Index helps organisations measure the key employee engagement AND happiness drivers to power their people strategy. Our unique platform offers the products, insights and tools to shine a light on your cultural health and empower management to drive thriving cultures. This helps you understand how employees think, feel and behave in real-time. Our neuroscience-based pre-built surveys measure the full employee experience - from onboarding to exit. By measuring the heart and brain of your organisation, we empower and enable managers to move from feedback to insight to action seamlessly. * Book a demo today - https://thehappinessindex.com/demo/ *
Investor
Apr 2022
Tipple allows alcohol brands to sell directly to consumers across 11 European countries. We handle taxes and logistics allowing you to focus on growing your brand.
Investor
Feb 2022
The ultimate insurance and retirement platform for modern companies. We make it extraordinarily easy to roll out and manage benefits globally.
2021
Investor
Dec 2021
Occuitys mission is to improve the lives of hundreds of millions of people by developing painless, contact-free screening & monitoring solutions for health conditions such as #diabetes, #myopia, #glaucoma and #Alzheimers Disease. Occuity is a UK-based medical technology company specialising in the research, design, and production of handheld non-contacting optical instruments for use in healthcare, diagnostics, and monitoring. Occuity’s scanning technology uses light to obtain precise measurements of different structures within the eye. This will enable direct measurements of the eye for optometrists and ophthalmologists but also other more general health conditions such as diabetes and Alzheimer’s Disease to be monitored. Occuitys IP includes 9granted international patents with a further 5 applications. Our Products Optometry & Ophthalmology: Were designing and developing a range of handheld, optical non-contacting devices. Our first device will be the world’s first handheld, non-contacting optical pachymeter – The Occuity PM1 – due to launch in 202. The underlying technology in the PM1 will be built upon to look at other measurements within the eye including, axial length, pupillometry and keratometry for use in both human and veterinary optometry. Disease Screening Building upon our patented technology, Occuitys disease screening products, will make it easier and cheaper to screen for diseases such as diabetes and Alzheimers in non-clinical settings such as high street opticians, pharmacies and care homes. Disease Monitoring Occuity’s vision is to deliver the world’s first non-invasive, non-contacting glucose monitor. Instead of relying on finger stick blood tests to provide blood glucose readings, Occuity is in the process of researching & developing a non-contact handheld optical device to determine the blood glucose level by measuring subtle changes within the anterior chamber of the eye.
Show all 7 entries ↓
Investment activity
2021–2022 · 7 investments
2021320224
Recent (last 2 years)Earlier